Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Law
Competition And Relevant Markets In The Pharmaceutical Industry: The Case Of Pah Drugs, Kevin C. Green
Competition And Relevant Markets In The Pharmaceutical Industry: The Case Of Pah Drugs, Kevin C. Green
Kevin C Green
The nature and extent of competition between different therapies for a given medical condition often is a critical and controversial issue in both antitrust cases and in general strategic analysis in the pharmaceutical industry. The market for pulmonary arterial hypertension (“PAH”) therapies provides an interesting case study for analyzing these issues. An event study analyzing how the stock prices of PAH therapy providers respond to competitive developments sheds light on the nature of competition among different types of therapies. The results support the view that not all drugs for a given medical condition should necessarily be included in the same …
Regulation Of Pharmacy Benefit Managers: An Economic Analysis Of Regulation And Litigation As Agents Of Health Care Change, Kevin C. Green
Regulation Of Pharmacy Benefit Managers: An Economic Analysis Of Regulation And Litigation As Agents Of Health Care Change, Kevin C. Green
Kevin C Green
Pharmacy benefit managers or “PBMs” have come under intense legal and regulatory scrutiny in recent years. Each of the major PBMs has been targeted by public and private litigation including a major ongoing task force comprised of U.S. Attorneys and Attorneys General from twenty states. Moreover, more than 30 bills to regulate PBMs have been introduced in state legislatures since 2002. This paper provides an economic analysis of PBM regulation. I analyze the economic arguments put forward on both sides of the regulation debate and evaluate the existing empirical evidence on PBM conduct in the context of these arguments. I …